Community Pharmacists' Perspectives on Dispensing Medications With the Potential for Misuse, Diversion, and Intentional Overdose: Results of a Province-Wide Survey of Community Pharmacists in Canada

被引:14
作者
Leong, Christine [1 ]
Alessi-Severini, Silvia [1 ]
Sareen, Jitender [1 ]
Enns, Murray W. [2 ]
Bolton, James [2 ]
机构
[1] Univ Manitoba, Coll Pharm, Winnipeg, MB, Canada
[2] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada
关键词
Community pharmacy; drug misuse; safety; overdose; diversion; dispensing; pharmacist; PRESCRIPTION DRUG MISUSE; MONITORING PROGRAMS; LEGISLATION; ABUSE;
D O I
10.1080/10826084.2016.1197261
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Community pharmacists frequently encounter patients at risk of medication misuse, diversion, and intentional overdose. However, few studies have examined the perspective of the pharmacist on the identification and management of these patients. Objective: To understand the perspective of community pharmacists on the dispensing of select medications commonly associated with misuse, diversion, and overdose. Methods: An online survey was disseminated by electronic mail to community pharmacists listed in the College of Pharmacists of Manitoba directory. The survey was open from July to September 2014. Descriptive statistics were used to describe demographic information of the pharmacist and practice setting, and pharmacists' perceptions on the dispensing of select medications. Results: A total of 82 community pharmacists completed the survey. Most pharmacists considered a one-month supply appropriate for a psychotropic agent; but a 7-10 day-supply was considered appropriate for an opioid for acute pain. Factors that aid pharmacist decisions on providing select medications to patients include familiarity with the patient, ease of access to medical history information, and ease of access to the prescribing physician. Only 10.3%, 16.2%, and 32.4% felt they have received adequate training on the management of patients at risk for suicide, drug diversion, and medication misuse, respectively. Conclusion: Findings from this study demonstrated a need for improved systems for managing patients at risk for medication misuse, diversion, and overdose. Strategies that warrant further attention for limiting the means of medication misuse include increased access to electronic medical records and providing additional continuing education support for community pharmacists.
引用
收藏
页码:1724 / 1730
页数:7
相关论文
共 14 条
[1]  
[Anonymous], 2013, WORLD DRUG REP 2013
[2]   Abusive Prescribing of Controlled Substances - A Pharmacy View [J].
Betses, Mitch ;
Brennan, Troyen .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (11) :989-991
[3]  
College of Pharmacists of Manitoba, 2014, MAN PRESCR PRACT PRO
[4]   Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011 [J].
Fischer, Benedikt ;
Jones, Wayne ;
Urbanoski, Karen ;
Skinner, Roger ;
Rehm, Juergen .
DRUG AND ALCOHOL REVIEW, 2014, 33 (01) :19-26
[5]   UK legislation on analgesic packs: before and after study of long term effect on poisonings [J].
Hawton, K ;
Simkin, S ;
Deeks, J ;
Cooper, J ;
Johnston, A ;
Waters, K ;
Arundel, M ;
Bernal, W ;
Gunson, B ;
Hudson, M ;
Suri, D ;
Simpson, K .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7474) :1076-1079
[6]   Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study [J].
Hawton, K ;
Townsend, E ;
Deeks, J ;
Appleby, L ;
Gunnell, D ;
Bennewith, O ;
Cooper, J .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7296) :1203-1207
[7]   An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions [J].
Islam, M. Mofizul ;
McRae, Ian S. .
BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
[8]   Pharmaceutical Overdose Deaths, United States, 2010 [J].
Jones, Christopher M. ;
Mack, Karin A. ;
Paulozzi, Leonard J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (07) :657-659
[9]  
Kahan M, 2011, CAN FAM PHYSICIAN, V57, pE448
[10]  
National Association of Pharmacy Regulatory Authorities (NAPRA), 2014, NAT STAT PROV TERR S